{"ticker":"SRPT","companyName":"Sarepta Therapeutics, Inc.","fiscalYear":2025,"executiveName":"Douglas S. Ingram","executiveTitle":"Chief Executive Officer","totalComp":7840666,"salary":1171425,"stockAwards":6000005,"nonEquityIncentive":649000,"otherComp":20236,"yoyChangePct":296.37639617286607,"source":{"filingType":"DEF 14A","filingDate":"2026-04-24","filingUrl":"https://www.sec.gov/Archives/edgar/data/873303/000119312526177247/srpt-20260424.htm"},"lastUpdated":"2026-05-03T12:02:03.519Z"}